$4.78
0.153.24%
At close: -
$4.78
0.000.00%
After Hours: Dec 20, 4:58 PM EDT
Vanda Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Vanda Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.09 | $-0.16 | 43.8 % |
Jun 2024 | 2024-07-31 | $-0.08 | $-0.21 | 61.9 % |
Mar 2024 | 2024-05-08 | $-0.07 | $0.05 | -240.0 % |
Dec 2023 | 2024-02-07 | $-0.04 | $-0.09 | 55.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $47.65M | $49.15M | -3.05 % |
Jun 2024 | 2024-07-31 | $50.47M | $47.86M | 5.46 % |
Mar 2024 | 2024-05-08 | $47.46M | $48.50M | -2.14 % |
Dec 2023 | 2024-02-07 | $45.27M | $37.00M | 22.4 % |
Vanda Pharma (VNDA) is scheduled to report earnings on February 5, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-0.09, which beat the estimate of $-0.16.
The Actual Revenue was $47.7M, which missed the estimate of $49.1M.
Browse earnings estimates, EPS, and revenue on all stocks.